NEW YORK, June 28, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Thursday, July 6:
Following is a summary of the changes that will take place prior to the open of trading on the effective date:
Effective Date | Index Name | Action | Company Name | Ticker | GICS Sector |
July 3, 2023 | S&P 500 | Addition | Fortrea Holdings | FTRE | Health Care |
July 5, 2023 | S&P 500 | Addition | PHINIA | PHIN | Consumer Discretionary |
July 6, 2023 | S&P 500 | Deletion | Fortrea Holdings | FTRE | Health Care |
July 6, 2023 | S&P 500 | Deletion | PHINIA | PHIN | Consumer Discretionary |
July 6, 2023 | S&P SmallCap 600 | Addition | Fortrea Holdings | FTRE | Health Care |
July 6, 2023 | S&P SmallCap 600 | Addition | PHINIA | PHIN | Consumer Discretionary |
July 6, 2023 | S&P SmallCap 600 | Deletion | Seneca Foods | SENEA | Consumer Staples |
July 6, 2023 | S&P SmallCap 600 | Deletion | El Pollo Loco Holdings | LOCO | Consumer Discretionary |
For more information about S&P Dow Jones Indices, please visit www.spdji.com
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.
FOR MORE INFORMATION:
S&P Dow Jones Indices
This email address is being protected from spambots. You need JavaScript enabled to view it.This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries
This email address is being protected from spambots. You need JavaScript enabled to view it.This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$252.72 |
| Daily Change: | 6.08 2.47 |
| Daily Volume: | 1,170,215 |
| Market Cap: | US$20.980B |
October 28, 2025 October 23, 2025 September 30, 2025 July 30, 2025 | |

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load